CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities
Net (loss) income	$ (7,537,000)	$ (4,336,000)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	26,000	14,000
Amortization of debt discount and debt issuance costs		1,090,000
Reduction in accounts payable from expiration of statute of limitations	(316,000)
Change in fair value of derivative liabilities	5,095,000	2,688,000
Stock issued in lieu of cash		13,000
Stock-based compensation	299,000	160,000
Change in assets and liabilities
Accounts receivable, net	200,000	(72,000)
Inventory, net	(70,000)	(9,000)
Other assets	(28,000)	(19,000)
Accounts payable	(82,000)	(13,000)
Deferred revenue	139,000	(326,000)
Billings in excess of costs and estimated earnings on uncompleted contracts		(241,000)
Accrued expenses	(485,000)	328,000
Pension obligation	6,000	41,000
Total adjustments	4,784,000	3,654,000
Net cash used in operating activities	(2,753,000)	(682,000)
Cash flows from investing activities
Purchase of property and equipment	(110,000)	(8,000)
Net cash used in investing activities	(110,000)	(8,000)
Cash flows from financing activities
Proceeds from exercised stock options	1,000	4,000
Proceeds from exercised stock purchase warrants		655,000
Dividends paid	(203,000)
Repayment of notes payable	(45,000)
Proceeds from issuance of notes payable		500,000
Net cash (used in) provided by financing activities	(247,000)	1,159,000
Effect of exchange rate changes on cash	(15,000)	(84,000)
Net increase (decrease) in cash and cash equivalents	(3,125,000)	385,000
Cash and cash equivalents at beginning of period	6,773,000	103,000
Cash and cash equivalents at end of period	3,648,000	488,000
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Summary of non-cash investing and financing activities:
Warrants issued with notes payable		187,000
Beneficial conversion feature of convertible debt		188,000
Issuance of common stock pursuant to cashless warrant exercises	690,000	12,000
Reclassification of warrants previously classified as derivative liabilities to additional paid-in capital	13,588,000
Warrants issued for intangible asset purchase	87,000
Contingent royalty payment	72,000
Acquisition iof intangible assets	$ (159,000)